Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

Flow Cytometer

By Drug Discovery Trends Editor | March 12, 2010

BD Biosciences, a segment of BD, announced the launch of the BD FACSAria III Cell Sorting System, a next-generation flow cytometer with the ability to run complex multicolor experiments using up to six lasers.

“As the pioneer in flow cytometry, BD Biosciences’ goal is to expand the range of applications that can benefit from this technology by building innovative, powerful tools that are easier to use and more accessible to a larger number of life science researchers,” said James Glasscock, President, BD Biosciences – Cell Analysis. “The new BD FACSAria III system reflects this effort by providing researchers the flexibility to configure a system that meets their application requirements and budgets today, with the ability to expand its capabilities later to meet future needs.”

Innovations in the new BD FACSAria III Cell Sorting System include:

•  A next-generation gel coupled cuvette in the flow cell ensures that the system’s lasers are focused precisely on the sample stream and that they generate the greatest signal to maximize the amount of emitted light. Most importantly, it improves collection efficiency and optimizes the resolution needed for multicolor applications, even at high-speed sorting settings.

•  The instrument’s advanced optical system works efficiently to maximize signal detection as well as greatly increase the sensitivity and resolution for each color in a multicolor assay. Enhanced sensitivity and resolution helps readily identify and sort dim cell populations. In addition, the system’s next-generation flow cell is designed to improve resolution for side population applications and DNA cell cycle analyses.

•  A new expandable architecture uses an X-mount optical plate that allows the system to be expanded to support up to six laser wavelengths—633 nm, 561 nm, 488 nm, 445 nm, 405 nm and 375 nm—as well as up to 20 detector positions that can be used simultaneously.

•  A backwards-compatible architecture allows customers to upgrade existing instruments to the new BD FACSAria III platform. With a field upgrade, laboratories with a BD FACSAria or BD FACSAria II system can upgrade to the new capabilities of the BD FACSAria III system.

Date: February 25, 2010
Source: BD Biosciences

 


Filed Under: Drug Discovery

 

Related Articles Read More >

Lokavant’s Spectrum v15 uses AI to cut trial-feasibility modeling from weeks to minutes
Prime time for peptide-based drug discovery 
Why smaller, simpler molecular glues are gaining attention in drug discovery
Glass vial, pipette and woman scientist in laboratory for medical study, research or experiment. Test tube, dropper and professional female person with chemical liquid for pharmaceutical innovation
Unlocking ‘bench-to-bedside’ discoveries requires better data sharing and collaboration
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE